AIS10 – Aarhus Immunotherapy Symposium, 10th Anniversary Meeting

A Decade of Discovery: Celebrating Collaboration at
the 10th Aarhus Immunotherapy Symposium (AIS)
Thursday 14 November 2024
Aula, Aarhus University

12:00-13:00 Registration
13:00-13:05 Welcome by the Vice-Dean for Research, Faculty of Health, Per Höllsberg
Session 1: Chair Thomas Vorup-Jensen & Poul Sørensen
13:05-13:50 Paul Peter Tak, Candel Therapeutics, Boston, US (Keynote): Off-the-shelf product,
individualized anti-tumor immune response: Reprogramming the immune system by viral
immunotherapy for the treatment of solid tumors
13:50-14:40 Johanne Tracey Jacobsen, Oslo University, NO: Germinal center guided design of
therapeutic monoclonal antibodies
14:15:10 Sophia Karagiannis, Epsilogen & King’s College, UK: AllergoOncology – IgE immunotherapy
to activate immune responses against solid tumours
15:10-15:30 Break
Session 2: Chair Hans Jürgen Hoffmann & Poul Sørensen
15:30-16:00 Petra Bacher, Universitätsklinikum Schleswig-Holstein, Kiel, DE: T cell mechanisms in
Autoimmunity & Allergy
16:00-16:30 Nick Laursen, Commit Biologics, DK: An antibody platform to potentiate complement
activation for the treatment of cancer and autoimmune diseases
16:30-17:00 Inge Marie Svane, Herlev University Hospital, DK: Reaching beyond checkpoint
inhibitors to defeat cancer by immunotherapy
17:00-17:30 Break
Session 3: Chair Martin K. Thomsen & Søren E. Degn
17:30-18:00 Johannes Sam, Roche, Basel, CH: CD20 T cell bispecs and CD19 costimulators for B cell
malignancies
18:00-18:30 Nicola Ferrari, AstraZeneca, UK: CAR-T in autoimmune disease
18:30-19:00 Eric Vivier, Innate Pharma, FR: Harnessing innate immunity in cancer therapy and
beyond
19:00-20:00 Cocktail Dînatoire

Sign up here